Afficher la notice abrégée

dc.contributor.authorZIMMER, Robert H.
hal.structure.identifierChimie et Biologie des Membranes et des Nanoobjets [CBMN]
dc.contributor.authorGUICHARD, Gilles
IDREF: 084339268
dc.contributor.authorFREMAUX, Juliette
dc.contributor.authorGOUDREAU, Sebastien
dc.contributor.authorVENIN, Claire
dc.contributor.authorMAURAN, Laura
dc.date.accessioned2020-04-22T07:47:13Z
dc.date.available2020-04-22T07:47:13Z
dc.date.issued2019
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/4324
dc.description.abstractEnThe present description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal. In particular, the present disclosure relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the present disclosure may optionally be administered with at least one of a pharmaceutically acceptable excipient, additional pharmacologically active agent or a combination thereof.
dc.language.isoENen_US
dc.title.enPeptide-oligourea foldamer compounds and methods of their use
dc.typeBreveten_US
dc.subject.halChimie/Matériauxen_US
bordeaux.hal.laboratoriesInstitut de Chimie & de Biologie des Membranes & des Nano-objets (CBMN) - UMR 5248en_US
bordeaux.institutionBordeaux INPen_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.countryfr
bordeaux.brevet.numberEP 3 466 979 A1en_US
hal.identifierhal-03182518
hal.version1
hal.date.transferred2021-03-26T12:45:37Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.date=2019&rft.au=ZIMMER,%20Robert%20H.&GUICHARD,%20Gilles&FREMAUX,%20Juliette&GOUDREAU,%20Sebastien&VENIN,%20Claire&rft.genre=unknown


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée